Search Autoimmune Association
Share this article

Clinical Trials: What Patients Need to Know

Key Takeaways

  • What are autoimmune clinical trials? – Research studies involving volunteers that help scientists evaluate new medical treatments, such as drugs, therapies, and devices, to improve symptom management strategies.
  • What does participation involve? – Although each study is unique, many involve routine medical evaluations after treatment administration with bloodwork, imaging, and questionnaires to track symptoms.
  • Are autoimmune disease clinical trials safe? – Due to their experimental nature, clinical trials do carry potential risks and uncertainties, but they follow strict safety and ethical standards and include detailed medical monitoring.
  • What are the potential benefits? – By consenting to participate in an autoimmune disease clinical trial, you may get access to emerging therapies and closer medical supervision, while facilitating research efforts.

The Importance of Clinical Trials for Autoimmune Patients

For decades, autoimmune clinical trials have paved the way for more effective care. These volunteer-based studies have enabled researchers to evaluate potential therapies and deepen their understanding of autoimmune diseases, which is key to refining treatment strategies. In fact, autoimmune disease clinical trials are the main reason many approved treatments, such as biologics and biosimilars, exist and help patients manage their symptoms today.

Despite the significant progress already made, clinical trials remain incredibly important because many autoimmune conditions are still difficult to diagnose, unpredictable to manage, or resistant to existing therapies—and for many autoimmune conditions, no therapies exist at all. There are many autoimmune clinical trials available that are still in need of consenting, well-informed participants.

While questions about safety, potential side effects, and the clinical trial process are common, a greater understanding can help patients feel informed and empowered to make decisions that align with their needs, goals, and personal circumstances. The guide below is designed to educate and empower patients to help them weigh research-related opportunities that may arise during their healthcare journey.

What Clinical Trials Are & Their Purpose

Clinical trials are research studies that rely on volunteers to help scientists evaluate new medical treatments, therapies, devices, or approaches to care. While some clinical trials can focus on things like disease prevention and quality of life, in the world of autoimmune medicine, clinical trials usually focus on things like:

  • Testing new medications
  • Refining treatment combinations
  • Studying disease progression
  • Improving symptom management strategies

Clinical trials also help researchers better understand how autoimmune diseases behave in different populations. Since autoimmune conditions can affect people differently based on genetics, age, sex, environment, and disease severity, diverse patient participation is essential.

The Main Objective

Unlike standard medical care, which focuses on treating individual patients with established therapies, clinical trials are designed to answer scientific questions that may benefit both current and future patients.

Some examples of simplified questions researchers may study through autoimmune disease clinical trials are:

  • Is a new medication safe?
  • Does it work better than existing treatments?
  • Does it reduce side effects?
  • Can it slow disease progression?
  • Does it improve daily functioning or quality of life?

You can explore open clinical trials on our website or sign up for our Research Roundup newsletter to stay in the loop about autoimmune clinical trial news, which often highlights emerging therapies that target the immune system more precisely. 

How Clinical Trials Work

Clinical trials are typically conducted in phases, with each phase answering different questions about a treatment’s safety and effectiveness. The table below illustrates how typical autoimmune disease clinical trials work.

Trial Phase Primary Goal Typical Number of Participants What Researchers Evaluate
Phase I Safety and dosage 20 to 80 Side effects, safe dose ranges, and how the body responds
Phase II Effectiveness 100 to 300 Whether the treatment works through additional safety monitoring
Phase III Comparison Several hundred to a few thousand How the treatment compares to existing therapies in larger groups

 

Sometimes, autoimmune disease clinical trials continue into Phase IV after the U.S. Food and Drug Administration (FDA) approves the drug or device, to monitor long-term safety and effectiveness in even broader populations.

How a Trial’s Integrity is Protected

Researchers use several tools and methods to ensure studies produce reliable and unbiased results, such as:

  • Randomization – In many studies, participants are randomly assigned to different treatment groups to help reduce bias and improve the accuracy of study results.
  • Control groups – Some participants may receive the current standard treatment, while others receive the experimental therapy to help determine whether the new treatment offers meaningful benefits.
  • Placebos – Although they aren’t used in every study, sometimes an inactive substance designed to resemble the treatment being tested is used to help researchers determine whether the treatment is truly having an effect.

It is important to note that participation in a clinical trial does not mean a patient loses access to medical care—clinical teams closely monitor participants throughout the study and adjust care when necessary. Even though there is risk involved, safety is a top priority.

Safety and Patient Protections

Understandably so, one of the most common concerns surrounding clinical trials involves patient safety. While no medical treatment is entirely risk-free, modern autoimmune clinical trials are highly structured, carefully monitored studies designed to protect patients as they search for answers to important medical questions. 

Researchers, physicians, and regulatory agencies, such as the U.S. Department of Health and Human Services, work together to ensure that ethical standards are upheld at every stage of the process. As a result, patients participating in autoimmune clinical trials can expect the following three safety-related elements.

Informed Consent

Before joining a study, participants go through an informed consent process where researchers explain things like:

  • The purpose of the study
  • Potential risks and benefits
  • Required procedures
  • Possible side effects
  • Time commitments
  • Alternative treatment options

During this stage, participants should ask questions and review information carefully before committing to join; however, you can leave a clinical trial at any time, for any reason.

Independent Review Boards

Clinical trials are reviewed by Institutional Review Boards (IRBs) or ethics committees, which are made up of three classifications of people:

  1. Medical professionals
  2. Scientists
  3. Community representatives

These groups help ensure that studies are ethical and that participants’ rights are protected.

Ongoing Monitoring

Participants are monitored closely throughout the study through methods like:

  • Lab testing
  • Physical examinations
  • Symptom tracking
  • Imaging studies
  • Regular communication with research staff

If safety concerns arise, studies can be modified or stopped entirely.

Why Do Patients Join Clinical Trials?

People choose to participate in autoimmune clinical trials for many different reasons—some hope to access promising therapies not yet widely available, while others want to contribute to scientific progress that may help future patients. 

For instance, Shadé joined her first lupus study because she wanted to ensure autoimmune disease clinical trials better represent all communities. You can check out Shadé’s clinical trial journey in the video below to learn more about her motivations. 

Potential Benefits of Participating

Three of the most common reasons people choose to participate in autoimmune clinical trials include:

  1. Access to emerging treatments – Some studies provide access to therapies years before they become commercially available, making clinical trials particularly attractive to patients with limited treatment options.
  2. Increased medical monitoring – Clinical trial participants often receive frequent evaluations and close follow-up from specialized healthcare teams, making it easier to detect changes in disease activity early.
  3. Contributing to future care – Participation in research directly advances medical progress. Even when a treatment ultimately proves ineffective, the information gathered can still improve future research and patient care.

Understanding the Risks and Unknowns

Although clinical trials can offer potential opportunities, they also involve a degree of uncertainty, especially during earlier trial phases. Individual experiences and comfort levels may vary, and many patients find it helpful to consider both the potential benefits and unknowns while learning about the safeguards built into modern clinical research.

Some things to keep in mind about experimental therapies are:

  • They can cause side effects
  • They may fail to improve symptoms
  • They can work differently than expected
  • They may require significant time commitments

Potential risks are carefully explained before enrollment to help patients weigh the benefits and concerns in consultation with their current healthcare providers and support systems. There is no universally “right” decision about participation—what matters most is that patients feel informed, respected, and comfortable with their choice.

Common Misconceptions About Clinical Trials

There are many common misconceptions about autoimmune clinical trials, and having accurate information can help patients better understand these opportunities and make informed decisions. The table below outlines common myths about autoimmune clinical trials and the facts behind them.

Myth The Truth
Participants are callously treated like test subjects Clinical trials are heavily regulated and patient-centered. Researchers must follow strict ethical standards designed to protect participants’ well-being and rights.
Patients receive no treatment Many autoimmune disease clinical trials compare experimental therapies against standard treatments already in use. Even in placebo-controlled trials, patients continue receiving appropriate medical supervision.
Clinical trials are only for people who are severely ill Some trials focus on newly diagnosed patients, people with mild disease, or individuals who are stable on current therapies. Eligibility varies depending on the study’s goals.
Leaving a trial is not allowed Participation is voluntary. Patients can withdraw at any point if they feel uncomfortable or decide the study is no longer right for them.

 

Who Can Participate and What to Expect

Not every clinical trial is appropriate for every patient. Each study has eligibility criteria designed to protect participants and ensure accurate results.

Six of the most common eligibility factors for autoimmune disease clinical trials are:

  1. Specific diagnosis
  2. Age range
  3. Disease severity
  4. Prior treatments
  5. Current medications
  6. Other medical conditions

Meeting the established requirements helps researchers study therapies safely and effectively within defined populations.

What Participation May Involve

Participation varies from study to study, but may include things like:

  • Medication administration or device use
  • Recurring medical evaluations
  • Bloodwork and imaging
  • Questionnaires for symptom tracking

Some trials are conducted at major medical centers, while others allow partial remote participation via telemedicine or local lab work.

What to Ask before Participating in a Clinical Trial

Six questions patients considering participation should ask are:

  1. What are the goals of the study?
  2. How long will participation last?
  3. What side effects are known?
  4. Will travel be required?
  5. What costs are covered?
  6. How will my current treatments be affected?

Understanding expectations beforehand can reduce stress and help patients make more confident decisions.

The Emotional Side of Clinical Trial Participation

Clinical trial participation is not only a medical decision; it can also be an emotional one.

For many people living with autoimmune disease, participating in research creates a sense of empowerment. Rather than feeling passive in the face of illness, patients may feel actively involved in shaping future care and contributing to scientific progress. 

Other patients may feel anxious about uncertainty or fear disappointment if an experimental treatment does not work. Family members may also have concerns or differing opinions about participation that can pose challenges for the patient.

Open communication with healthcare providers, loved ones, and research staff can help patients navigate these emotions more comfortably.

The Growing Future of Autoimmune Research

There has been a ton of breakthrough research in the world of autoimmune medicine. Scientists are studying increasingly targeted approaches to regulate immune activity better while minimizing side effects.

Some areas of ongoing investigation include:

  • Biologic therapies
  • Cell-based therapies
  • Precision medicine
  • Gene-targeted treatments
  • Biomarker-guided care

As scientific understanding grows, autoimmune clinical trials become more personalized and sophisticated, inspiring hope for more effective therapies and improved quality of life in the future.

Making Informed Decisions About Participation

Fear and uncertainty are common when considering autoimmune disease clinical trials. However, understanding how research works can make the decision-making process easier.

The Autoimmune Association offers educational resources, advocacy opportunities, and updates related to autoimmune clinical trials and emerging research. Patients seeking additional guidance can explore these resources to stay informed about ongoing studies, treatment developments, and opportunities to connect with the broader autoimmune community.

After taking the time to ask questions, review risks, and secure second opinions, some patients may decide research participation aligns with their goals and values. In contrast, others may prefer standard treatment approaches. The decision is deeply personal and should be respected either way.

Regardless, if you still have questions about autoimmune disease clinical trials, you can email our team for more general insight.

Share this article

Join our email list

Receive the latest blog articles, news, and more right to your inbox!

Related articles you might be interested in

Autoimmune Association Image Do Not Touch

Hormones, Perimenopause, Menopause & Autoimmune Disease

Executive Summary Perimenopause is the transitional and often symptomatic phase that leads to menopause, which marks the end of an individual’s reproductive years...
Autoimmune Association Image Do Not Touch

Coping After Diagnosis: Support for Your Emotional Journey

A diagnosis of a chronic illness, such as autoimmune disease, can bring fear, uncertainty, and a sense that life has suddenly been divided...
Autoimmune Association Image Do Not Touch

Living With Multiple Autoimmune Diseases

Key Takeaways A patient is diagnosed with Multiple Autoimmune Syndrome (MAS) if they have at least three distinct autoimmune diseases. Nearly 25% of...
Autoimmune Association Image Do Not Touch

Jen’s EGPA Journey: Navigating a Rare Autoimmune Disease With Strength, Loss, and Hope

  Jen felt steady and strong. She had goals—buying investment property in Brisbane, building community, staying active in her work in aged care....

Find more resources on autoimmunity

Learn more about autoimmunity, diagnosis tips, how to find a physician, and more.